Urox Bladder Control Review (2026): The Trial Behind It, and the Hidden Dose

HerWellReport is reader-supported. This article contains affiliate links — see our affiliate disclosure. Nothing here is medical advice; see our medical disclaimer.

Search “Urox review” and almost nothing independent comes back — the brand’s own US site, the brand’s own Australian site, an Amazon listing, a couple of private-label versions sold under other names (Biote Nutraceuticals Urox+, Native Remedies Peace of Mind), and not much else. That’s unusual in this category for one reason: Urox is one of the only bladder-control supplement brands that has actually run — and published — a randomised, placebo-controlled trial on its finished formula. Most brands in this aisle have not. So this review is less about whether the ingredients “sound” evidence-based and more about what that trial actually found, what it didn’t, and why the dose printed on the label depends entirely on which of the brand’s own websites you’re reading.

The short version: the trial is real and its results are statistically strong, but it is a single, brand-funded, 8-week study with no active-drug comparator — and the exact milligram breakdown that matches the trial dose is published on Urox’s Australian site and missing from the US listing that most American buyers will actually see.

Short on time? Skip to what we’d look at instead →

What Urox actually is

Urox is a patented herbal blend owned by the Australian company Seipel Group, made from three extracts: Crataeva nurvala (sometimes labelled Crataeva magna) stem bark, standardised and sold under the brand name Cratevox; Equisetum arvense (horsetail) herb; and Lindera aggregata root. Seipel sells it directly in the US through uroxbladderhealth.com and on Amazon, and licenses it to other supplement brands — Biote Nutraceuticals’ “Urox+” and Native Remedies’ “Peace of Mind Bladder Control with Urox” are the same core blend under different labels. This review covers the ingredient combination and the flagship Urox-branded product specifically; the pricing and label details below are Seipel’s own.

The dose depends on which of the brand’s own sites you read

On the US site and Amazon listing, Urox is sold as a “proprietary blend” of 840 mg per two-capsule serving, with the three ingredients named but no individual milligram amounts given — the standard undisclosed-blend format we’ve flagged on other bladder brands. But Seipel’s own Australian manufacturer site, seipelhealth.com.au, itemises the same product down to the capsule: 150 mg horsetail extract (from 1,500 mg dry herb), 150 mg Lindera extract (from 1,500 mg root) and 120 mg Cratevox (from 3,000 mg dry stem bark) per capsule. Two capsules a day works out to 300 mg horsetail, 300 mg Lindera and 240 mg Cratevox — 840 mg total, matching the US “proprietary blend” figure exactly.

So the doses aren’t actually secret — the manufacturer publishes them, just not on the page most US buyers land on. That’s a real and useful thing to know before buying: the Australian label tells you precisely what you’re taking; the US Amazon listing doesn’t, even though it’s the identical formula.

The trial, and what it does and doesn’t show

The evidence behind Urox is a phase 2, randomised, double-blind, placebo-controlled trial published in BMC Complementary Medicine and Therapies in 2018¹. It enrolled 150 adults (59% female, average age 63.5) with overactive bladder symptoms; 142 completed the full 8 weeks. The treatment dose was two capsules a day — 840 mg of the same blend sold today.

The results were statistically strong across every measure reported. Daytime urinary frequency fell to 7.69 times a day in the treatment group versus 10.95 in the placebo group by week 8 (p<0.001). Nocturia (nighttime trips) fell to 2.16 versus 3.14 (p<0.05). Urgency episodes and incontinence episodes were both significantly lower in the treatment arm (p<0.01 for each). Sixty percent of the treatment group reached a “normal” daytime frequency by the end of the trial, versus 11% on placebo. Thirteen mild adverse events were reported in total — eight in the placebo arm, five in the treatment arm — and none caused anyone to withdraw.

Those are genuinely good numbers, and it’s worth saying plainly: this is a more rigorous piece of evidence than most brands in this category can point to. But three honest caveats matter as much as the numbers:

• It was funded by the company that makes the product. Trade press coverage at the time confirmed the trial was financed by Seipel Group, which holds the Urox patent². That doesn’t make the results false, but it means there’s no independent replication to check them against — this is the only published human trial of this formula we could find.
• There was no active-drug comparator. The trial compared Urox against placebo, not against a standard overactive-bladder medication (an anticholinergic, for instance). So it tells you Urox likely beats a sugar pill; it does not tell you how it compares to what a doctor would otherwise prescribe.
• The study population wasn’t specifically midlife or menopausal women. It was 59% female with an average age of 63.5, and results were not broken out separately by sex or by menopausal status. That’s a reasonably close match to this site’s audience, but it isn’t the same as a trial designed around perimenopausal or postmenopausal women specifically.

A separate 2022 rat study looked at the same blend’s effect on bladder muscle contraction and found supportive mechanistic results, but animal pharmacology is not a substitute for human outcome data and we’re not treating it as additional proof here.

Price and guarantee

Direct from Urox’s US site, one 60-capsule bottle (a 30-day supply at the standard two-capsules-a-day dose) is $39.95. Three bottles run $107.97 (about 10% off), and six bottles run $203.94 with free shipping (about 15% off). Auto-ship subscribers get complimentary shipping on top of that.

Urox backs its products with a 60-day money-back guarantee, covering empty or unopened bottles, refunded minus shipping and handling. This is sold directly by Seipel Group rather than through a third-party payment processor like ClickBank, which cuts both ways: there’s no separate processor-side refund window to worry about missing, but there’s also no independent backstop beyond the seller’s own word if a refund request gets slow-walked.

What to check before taking it

Horsetail (Equisetum arvense) is a diuretic, and WebMD’s ingredient monograph flags it as worth discussing with a prescriber if you’re already on a diuretic, on lithium, or on certain HIV/AIDS medications, since the interactions “are not fully understood”³. The same monograph advises disclosing kidney or liver problems, electrolyte imbalance (including low sodium), dehydration, or heart failure before taking it, and notes that its effects in pregnancy and breastfeeding are unknown.

Crataeva nurvala and Lindera aggregata have much thinner independent human safety data outside this one combination trial — most of what’s published on either ingredient on its own comes from traditional-use records rather than controlled human studies, so “well tolerated in an 8-week trial of this specific blend” is the honest extent of what can currently be said, not a broader safety guarantee.

FAQ

Is the Urox trial independently confirmed?
No. It’s the only published human trial of this formula we could find, and it was funded by Seipel Group, the company that makes and patents Urox. The results are statistically strong, but there’s no independent replication to check them against.

Why does the US listing say “proprietary blend” when the doses aren’t actually secret?
Seipel’s Australian site (seipelhealth.com.au) publishes the exact per-capsule milligram breakdown for all three ingredients. The US Amazon and direct-site listings show only the combined 840 mg total. Same formula, different disclosure on each site.

Is Urox studied specifically for menopausal or midlife women?
Not specifically. The published trial was 59% female with an average participant age of 63.5, and results weren’t broken out by sex or menopausal status. It’s a reasonably close match to this audience, not a purpose-built study of it.

Bottom line

Urox has something most bladder-control brands in this niche don’t: a real, published, placebo-controlled trial with statistically significant results on its actual finished formula, and a manufacturer that — at least on one of its own websites — will tell you the exact dose. That’s genuinely more than we can say for most of the competitors we’ve reviewed. It is not independently replicated, it wasn’t tested against a standard prescription option, and it wasn’t built around a menopausal population specifically. If you want to weigh it against a different mechanism aimed at urgency, irritation and the urinary microbiome rather than bladder-muscle symptoms, our honest FemiCore review is the place to compare notes before spending on either one.

More from HerWellReport

• FemiCore Review: Does It Actually Help With Bladder Control?
• Best Bladder Control Supplements for Women (2026): What’s Actually in Them
• Cystex Review: What’s Actually in the Cranberry Liquid?
• Swanson Go-Less Bladder Control Review
• Confitrol24 Review: The Trial Is Real, But the Label Doesn’t Say How Much